Permanent Radiotherapy Implants Reduce Risk Of Prostate Cancer Recurrence By 5 Years

Permanent Radiotherapy Implants Reduce Risk Of Prostate Cancer Recurrence By 5 Years
Recent results of a controlled, randomized clinical trial comparing the use of permanent radioactive implants (brachytherapy) with external beam, dose-escalated radiotherapy in individuals suffering with prostate cancer revealed that patients who received brachytherapy were 2 times more likely to be cancer-free 5 years after treatment. The results were presented by James Morris, professor at the Department of Radiation Oncology, Vancouver Cancer Centre, British Columbia Cancer Agency (BCCA),

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , .

Isaura Santos graduated with a BS in Cell and Molecular Biology from Universidade Nova de Lisboa and a MA in Communication, Culture and Information Technologies from University Institute of Lisbon (ISCTE-IUL). Her professional interests include science communication, public awareness of science and communication of science through entertainment.

Leave a Comment

Your email address will not be published. Required fields are marked *